CA3290580A1 - Compositions and methods for treating clostridioides difficile infection - Google Patents

Compositions and methods for treating clostridioides difficile infection

Info

Publication number
CA3290580A1
CA3290580A1 CA3290580A CA3290580A CA3290580A1 CA 3290580 A1 CA3290580 A1 CA 3290580A1 CA 3290580 A CA3290580 A CA 3290580A CA 3290580 A CA3290580 A CA 3290580A CA 3290580 A1 CA3290580 A1 CA 3290580A1
Authority
CA
Canada
Prior art keywords
compositions
treating
methods
difficile infection
clostridioides difficile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3290580A
Other languages
French (fr)
Inventor
Rajita Menon
Jason Norman
Bernat Olle
Original Assignee
Vedanta Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vedanta Biosciences Inc filed Critical Vedanta Biosciences Inc
Publication of CA3290580A1 publication Critical patent/CA3290580A1/en
Pending legal-status Critical Current

Links

CA3290580A 2023-04-28 2024-04-26 Compositions and methods for treating clostridioides difficile infection Pending CA3290580A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/498,985 2023-04-28

Publications (1)

Publication Number Publication Date
CA3290580A1 true CA3290580A1 (en) 2024-10-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP4157327A4 (en) Compositions and methods for preventing and treating sars-cov-2 infection
EP4164695A4 (en) Compositions and methods for treating gjb2-associated hearing loss
EP4093758A4 (en) Methods and compositions for treating and preventing viral infection
EP4096675A4 (en) Compositions and methods for treating long covid
EP4213820A4 (en) Methods and compositions for treating viral infections
EP4199950A4 (en) Methods and compositions for treating coronavirus infections
EP4281096A4 (en) Methods and compositions for treating infections
EP4216961A4 (en) Compositions and methods for treatment of coronavirus infection
EP4132539A4 (en) Compositions and methods for treating bacterial infections
EP4313065A4 (en) Methods and compositions for treating clostridiodes difficile infections
CA3290580A1 (en) Compositions and methods for treating clostridioides difficile infection
EP4161646A4 (en) Compositions and methods for treating virus infection
EP4380915A4 (en) Compositions and methods for treating mastitis
EP4175978A4 (en) Compositions and methods for treating crp-mediated diseases
CA3281552A1 (en) Compositions and methods for treating hyperprocalcitonemia
CA3278586A1 (en) Compositions and methods for treating alpha-synucleinopathies
AU2022900343A0 (en) Compositions and methods for treating infections
HK40101531A (en) Methods and compositions for treating viral infection
HK40096243A (en) Compositions and methods for treating viral infection
HK40085824A (en) Methods and compositions for treating and preventing viral infection
AU2020901796A0 (en) Compositions and methods for treatment
HK40108955A (en) Compositions and methods for treating and preventing viral infections
EP4367086A4 (en) Compositions and methods for treating and preventing viral infections
HK40085494A (en) Compositions and methods for treating and preventing prekallikrein-associated conditions
HK40101021A (en) Methods and compositions for treating viral infections